184 related articles for article (PubMed ID: 37691923)
1. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer.
Ma Y; Xing Y; Li H; Yuan T; Liang B; Li R; Li J; Li Z; Li S; Niu L
Front Immunol; 2023; 14():1193040. PubMed ID: 37691923
[TBL] [Abstract][Full Text] [Related]
2. Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis.
He C; Wang J; Zhang Y; Lin X; Li S
Pancreatology; 2020 Apr; 20(3):477-484. PubMed ID: 32131993
[TBL] [Abstract][Full Text] [Related]
3. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
4. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia.
Yang PC; Huang KW; Pua U; Kim MD; Li SP; Li XY; Liang PC
Eur J Surg Oncol; 2020 May; 46(5):811-817. PubMed ID: 31839436
[TBL] [Abstract][Full Text] [Related]
6. Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer.
He C; Sun S; Huang X; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():622318. PubMed ID: 33604301
[TBL] [Abstract][Full Text] [Related]
7. Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer.
He C; Sun S; Zhang Y; Li S
J Inflamm Res; 2021; 14():4795-4807. PubMed ID: 34584438
[TBL] [Abstract][Full Text] [Related]
8. A phase 1b trial of concurrent immunotherapy and irreversible electroporation in the treatment of locally advanced pancreatic adenocarcinoma.
O'Neill C; Hayat T; Hamm J; Healey M; Zheng Q; Li Y; Martin RCG
Surgery; 2020 Oct; 168(4):610-616. PubMed ID: 32631655
[TBL] [Abstract][Full Text] [Related]
9. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model.
Narayanan JSS; Ray P; Hayashi T; Whisenant TC; Vicente D; Carson DA; Miller AM; Schoenberger SP; White RR
Cancer Immunol Res; 2019 Oct; 7(10):1714-1726. PubMed ID: 31409607
[TBL] [Abstract][Full Text] [Related]
10. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
[No Abstract] [Full Text] [Related]
11. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
[TBL] [Abstract][Full Text] [Related]
12. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of combination of induction chemotherapy and irreversible electroporation ablation for patients with locally advanced pancreatic adenocarcinoma.
Huang KW; Yang PC; Pua U; Kim MD; Li SP; Qiu YD; Song TQ; Liang PC
J Surg Oncol; 2018 Jul; 118(1):31-36. PubMed ID: 29878378
[TBL] [Abstract][Full Text] [Related]
15. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC).
Oikonomou D; Karamouzis MV; Moris D; Dimitrokallis N; Papamichael D; Kountourakis P; Astras G; Davakis S; Papalampros A; Schizas D; Petrou AS; Felekouras E
Am J Clin Oncol; 2021 Jul; 44(7):325-330. PubMed ID: 33979098
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
He CB; Wang J; Mao YZ; Lao XM; Li SP
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
[No Abstract] [Full Text] [Related]
17. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival.
Woeste MR; Wilson KD; Kruse EJ; Weiss MJ; Christein JD; White RR; Martin RCG
Front Oncol; 2021; 11():817220. PubMed ID: 35096621
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Survival Between Irreversible Electroporation Followed by Chemotherapy and Chemotherapy Alone for Locally Advanced Pancreatic Cancer.
He C; Huang X; Zhang Y; Cai Z; Lin X; Li S
Front Oncol; 2020; 10():6. PubMed ID: 32038984
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
[TBL] [Abstract][Full Text] [Related]
20. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
Marsanic P; Mellano A; Sottile A; De Simone M
Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
